# Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002

> **NCT01992289** · — · UNKNOWN · sponsor: **Edimer Pharmaceuticals** · enrollment: 10 (actual)

## Conditions studied

- X-linked Hypohidrotic Ectodermal Dysplasia

## Interventions

- **DRUG:** EDI200

## Key facts

- **NCT ID:** NCT01992289
- **Lead sponsor:** Edimer Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01992289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01992289, "Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01992289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*